Verbio Ver.Bioenergie: CMD: Investment case confirmed, US upside emerging - NuWays AG Research

Verbio Ver.Bioenergie: CMD: Investment case confirmed, US upside emerging - NuWays AG Research

VERBIO’s CMD confirmed our investment case, highlighting c.€ 300m in normalised EBITDA potential from its existing asset base, alongside additional upside from US 45Z and 45Q tax incentives. Progress in renewable chemicals and a stronger focus on cash generation further support the outlook. We modestly raise our medium-term earnings estimates while reiterating BUY with an unchanged € 41 PT.

Länk till analysen i sin helhet: https://www.nuways-ag.com/research/cmd-investment-case-confirmed-us-upside-emerging